Literature DB >> 2833468

Myoepithelial cells in salivary gland tumors--revisited.

I Dardick1, A W van Nostrand.   

Abstract

It is an interesting parallel that the myoepithelial cell with its hybrid epithelial and mesenchymal structural and functional phenotype has a dual role in such salivary gland tumors as pleomorphic adenoma. This cell is responsible for considerable proportions of the epithelial component of this tumor, including squamous metaplasia, and is also the agent principally involved in the synthesis, organization, and cytologic modifications of the chondromyxoid regions. Neoplastically modified myoepithelial cells are also generally accepted to be a significant component of salivary gland tumors such as epithelial-myoepithelial carcinoma, certain adenocarcinomas, and, of course, myoepitheliomas. The range of myoepithelial cell alterations can be appreciated via ultrastructural assessment of the above four classes of salivary gland tumors. An electron microscopic survey of monomorphic adenomas, adenoid cystic carcinomas, and mucoepidermoid carcinomas reveals some having a tumor cell component with structural modifications and localization similar to the modified myoepithelial cells in pleomorphic adenomas and the adenocarcinomas noted above. Such ultrastructural findings have important implications for clarifying diagnostic problems, for understanding histogenetic relationships, and for improving the classification of salivary gland tumors.

Entities:  

Mesh:

Year:  1985        PMID: 2833468     DOI: 10.1002/hed.2890070509

Source DB:  PubMed          Journal:  Head Neck Surg        ISSN: 0148-6403


  19 in total

1.  Immunohistochemical and ultrastructural correlates of muscle-actin expression in pleomorphic adenomas and myoepitheliomas based on comparison of formalin and methanol fixation.

Authors:  I Dardick; V L Ostrynski; J K Ekem; R Leung; A P Burford-Mason
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  S-100 protein antibodies do not label normal salivary gland myoepithelium. Histogenetic implications for salivary gland tumors.

Authors:  I Dardick; M Stratis; W R Parks; F G DeNardi; H J Kahn
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

Review 3.  A perspective of comparative salivary and breast pathology. Part I: microstructural aspects, adaptations and cellular events.

Authors:  Asterios Triantafyllou; Jennifer L Hunt; Kenneth O Devaney; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-05-07       Impact factor: 2.503

4.  Immunolocalization of a human basal epithelium specific keratin in benign and malignant breast disease.

Authors:  S H Dairkee; B M Ljung; H Smith; A Hackett
Journal:  Breast Cancer Res Treat       Date:  1987-10       Impact factor: 4.872

5.  Basal cell adenoma in the parotid: a bizarre myoepithelial-derived stroma rich variant.

Authors:  Yong Huang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

6.  Characterization of cytoskeletal proteins in basal cells of human parotid salivary gland ducts.

Authors:  I Dardick; W R Parks; J Little; D L Brown
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

Review 7.  Clear cell entities of the head and neck: a selective review of clear cell tumors of the salivary glands.

Authors:  Nasser Said-Al-Naief; Michael J Klein
Journal:  Head Neck Pathol       Date:  2008-04-22

8.  Salivary gland myoepithelioma variants. Histological, ultrastructural, and immunocytological features.

Authors:  I Dardick; S Cavell; M Boivin; D Hoppe; W R Parks; J Stinson; S Yamada; B F Burns
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

9.  Myoepithelioma of the Parotid Gland Presenting as a Retroauricular Cutaneous nodule: A Case Report.

Authors:  Yumi Mochizuki; Ken Omura; Kae Tanaka; Kei Sakamoto; Akira Yamaguchi
Journal:  J Clin Diagn Res       Date:  2013-04-15

10.  Myoepithelioma of a minor salivary gland of the cheek: case report.

Authors:  E Ferri; I Pavon; E Armato; S Cavaleri; P Capuzzo; F Ianniello
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-02       Impact factor: 2.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.